Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders (AD) or major toxicity with ipilimumab (IPI) Meeting Abstract
| Authors: | Menzies, A. M.; Johnson, D. B.; Ramanujam, S.; Atkinson, V.; Wong, A. N. M.; Park, J. J.; McQuade, J. L.; Shoushtari, A. N.; Tsai, K. K.; Eroglu, Z.; Klein, O.; Hassel, J. C.; Sosman, J. A.; Guminski, A.; Sullivan, R. J.; Ribas, A.; Carlino, M. S.; Davies, M. A.; Sandhu, S. K.; Long, G. V. |
| Abstract Title: | Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders (AD) or major toxicity with ipilimumab (IPI) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 487s |
| Language: | English |
| ACCESSION: | WOS:000404711507137 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9515 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9515 -- Source: Wos |
